PNP Therapeutics, UAB and Southern Research Institute work abolishes otherwise unmanageable human cancers in preclinical rodent studies.
The fund will benefit cancer patients who are facing demonstrable financial hardship to help offset the cost of their treatment.
A Department of Neurosurgery, effective Oct. 1, 2013, will increase the profile of an internationally renowned program.
In this preliminary analysis, the study treatment neither built up in organs and nor destroyed the bone marrow’s ability to make blood cells.
The conference will feature current trends in the field as they relate to fertility and cancer, radiation therapy, fatigue syndrome, survivorship and palliative care.